Plamen Angelov
Marketing Manager Biosimilars for CEE at Alvogen- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Alvogen
-
United States
-
Pharmaceutical Manufacturing
-
300 - 400 Employee
-
Marketing Manager Biosimilars for CEE
-
Jul 2013 - Present
- Marketing of biosimilar filgrastim (Nivestim), epoetin alfa (Retacrit) and infliximab (Inflectra) in partnership with Hospira, a Pfizer Company - Launching Inflectra (infliximab, the first biosimilar monoclonal antibody registered by EMA) in Alvogen markets (Europe): • Central and Eastern Europe (CEE): Bulgaria, Croatia, Hungary, Poland, Romania • Baltic states: Estonia, Latvia, Lithuania • West Balkans: Albania, Bosnia and Herzegovina, Kosovo, Macedonia, Montenegro, Serbia • Iceland Show less
-
-
-
Pharmexport Communication
-
Sofia, Bulgaria
-
Marketing Excellence External Consultant
-
Jan 2013 - Jun 2013
Strategic input on marketing excellence and sales expertise Strategic input on marketing excellence and sales expertise
-
-
-
Abbott
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Medical Advisor Immunology
-
Jan 2012 - Dec 2012
- Scientific information management- Identify and liaise with outside experts and opinion leaders- Deliver medical information and training to marketing and sales persons - rheumatology, gastroenterology and dermatology fields
-
-
Product Manager Humira
-
Jan 2011 - Dec 2011
Developing Humira marketing strategy and implementation tactics - all indications
-
-
-
The Janssen Pharmaceutical Companies of Johnson & Johnson
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Product Manager CNS/Psychiatry
-
Jan 2005 - Dec 2010
Development and execution of country-wide marketing and sales strategy for Risperdal, Risperdal Consta and Invega- Re-launching Risperdal Consta- Launching Invega- Pre-launch of Invega Sustenna (paliperidone palmitate)
-
-
Key Account Manager
-
Aug 2003 - Dec 2004
CNS/Psychiatry - Risperdal; Risperdal Consta
-
-
-
Janssen-Cilag, Division of Johnson&Johnson
-
Sofia, Bulgaria
-
Medical Representative CNS/Psychiatry
-
Oct 2000 - Jul 2003
Promotion of Risperdal/Rispolept (both in schizophrenia and bipolar disorder) Promotion of Risperdal/Rispolept (both in schizophrenia and bipolar disorder)
-
-
-
Merck
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Product Manager
-
Jan 1999 - Sep 2000
- Marketing allergology and dermatology line- Launching 3 brands
-
-
Professional Sales Representative
-
Jun 1998 - Dec 1998
Promotion of allergology (Claritine, Clarinase); dermatology (Elocom, Diprosone, Diprogenta, Diprosalic, Diprophos); ophthalmology (Celestone, Garasone); anti-asthma (Aldecin) and OTC (Afrine) products
-
-
Education
-
Sofia Medical Univercity - Pharmaceutical Faculty
Master of Science (MSc), Pharmaceutical Sciences -
Romain Rolland Foreign Language School